Dehydroepiandrosterone sulfate does not prevent spontaneous and iodine- induced lymphocytic thyroiditis and diabetes mellitus in the BB/Wor rat

European Journal of Endocrinology

Volumn 138, Issue 6, 1998, Pages 719-723

  Alex, Sharon ^a   Braverman, Lewis E ^a,b   Fang, Shih Lieh ^a   Norvell, Beth ^a   Robinson, Sonya ^a   Franz, Charlene ^a   Longcope, Christopher ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE; PRASTERONE SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL DIABETES MELLITUS; FEMALE; HASHIMOTO DISEASE; HISTOLOGY; HYPERGLYCEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANIMALS; DEHYDROEPIANDROSTERONE SULFATE; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; IODINE; MALE; RATS; RATS, INBRED STRAINS; THYROID HORMONES; THYROIDITIS, AUTOIMMUNE;

EID: 0031810632     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1380719     Document Type: Article

References (51)

1. Barrett-Conner E, Khaw KT & Yen SS. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. New England Journal of Medicine 1986 315 1519-1524.
2. Gordon G, Bush DE & Weisman FH. Reduction of atherosclerosis by administration of dehydroepiandrosterone. Journal of Clinical Investigation 1988 82 712-720.
3. Schwartz A, Hard G, Pashko L, Abou-Gharbia M & Swern D. Dehydroepiandrosterone: an antiobesity and anticarcinogenic agent. Nutr Cancer 1981 3 46-53.
4. Avy/a mice by dehydroepiandrosterone. Lipids 1977 12 409-413.
5. Schwartz AG & Perantoni A. Protective effects of dehydroepiandrosterone against aflatoxin B and 7,12-dimethyl(a)anthracine-induced cytotoxicity and transformation in cultured cells. Cancer Research 1975 35 2482-2487.
6. Mohan PF. Dehydroepiandrosterone and Alzheimer's disease. (Letter). Lancet 1989 ii 1049.
7. Coleman DL, Schwizer RW & Leiter EH. Effect of genetic background on the therapeutic effects of dehydroepiandrosterone in diabetes-obesity mutants in aged normal mice. Diabetes 1984 33 26-32.
8. Coleman DL, Leiter EH & Schwizer RW. Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 1982 31 830-833.
9. Coleman DL, Leiter EH & Applezwerg N. Therapeutic effects of metabolites of dehydroepiandrosterone in diabetic mutant mice. Endocrinology 1984 115 239-243.
10. Leiter EH, Beamer WG, Coleman DL & Longcope C. Androgenic and estrogenic metabolites in the serum of mice fed dehydroepiandrosterone: relationship to anti-hyperglycemia effects. Metabolism 1987 36 863-869.
11. Leiter EH. The influence of genetic background on the expression of mutations at the diabetes locus IV. Male lethal syndrome in CBA/LT mice. Diabetes 1981 30 1035-1044.
12. Daynes RA, Araneo BA, Dowell TD, Huang K & Dudley D. Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. Journal of Experimental Medicine 1990 171 979-996.
13. Roubivian JR, Talal N, Greenspan JS, Goodman JR & Siiteri PK. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies and glomerulonephritis in N2B/NZW F1 mice. Journal of Experimental Medicine 1978 147 1568-1583.
14. Tanner RM & Schwartz AG. Reduced weight gain and delay of Coomb's positive hemolytic anemia in NZB mice treated with dehydroepiandrosterone (DHEA). Federation Proceedings 1982 41 463 (Abstract).
15. Nestler JE. Introduction: DHEA: a coming of age. Annals of the New York Academy of Sciences 1995 774 ix.
16. Robel P & Baulieu EE. Dehydroepiandrosterone (DHEA) is a neuroactive neurosteroid. Annals of the New York Academy of Sciences 1995 774 82-110.
17. Yen SSC, Morales AJ & Khorram O. Replacement of DHEA in aging men and women. Potential remedial effects. Annals of the New York Academy of Sciences 1995 774 128-142.
18. Schwartz AG & Pashko LL. Mechanism of cancer preventive action of DHEA. Role of glucose-6-phosphate dehydrogenase. Annals of the New York Academy of Sciences 1995 774 180-186.
19. Herrington DM. Dehydroepiandrosterone and coronary atherosclerosis. Annals of the New York Academy of Sciences 1995 774 271-280.
20. Flood JF & Roberts E. Dehydroepiandrosterone sulfate improves memory in aging mice. Brain Research 1988 448 178-181.
21. Migeon CJ, Keller AR, Lawrence B & Shepard TH II. Dehydroepiandrosterone and androsterone levels in human plasma. Effect of age and sex, day-to-day and diurnal variations. Journal of Clinical Endocrinology and Metabolism 1957 17 1051-1062.
22. Orentreich N, Brind JL, Rizer RL & Vogelman JN. Age changes and sex differences in serum dehydroepiandrosterone concentrations throughout adulthood. Journal of Clinical Endocrinology and Metabolism 1984 59 551-555.
23. Adams JB. Control of secretion and the function of C19- 5-steroids of the human adrenal gland. Molecular and Cellular Endocrinology 1985 41 1-17.
24. Harper MJK. Estrogenic effects of dehydroepiandrosterone and its sulfate in rats. Endocrinology 1969 84 229-255.
25. Tagliaferro AR & Davis JR. The effect of dehydroepiandrosterone (DHEA) on caloric intake, body weight and resting metabolism. Federation Proceedings 1983 43 326 (Abstract).
26. Familiari G, Toscano V & Motta PM. Morphological studies of polycystic mouse ovaries induced by DHEA. Cell and Tissue Research 1985 240 519-528.
27. Cleary MP, Shepherd A & Jenks B. Effect of dehydroepiandrosterone on growth in lean and obese Zucker rats. Journal of Nutrition 1984 114 1242-1251.
28. Oertel GW & Benes P. The effect of steroids on glucose-6-phosphate dehydrogenase. Journal of Steroid Biochemistry 1972 3 493-496.
29. McCormick DL, Rao KV, Johnson WD, Bowman-Gram TA, Steele LE, Lubet RA & Kellof GJ. Exceptional chemopreventive activity of low dose dehydroepiandrosterone in the rat mammary gland. Cancer Research 1996 56 1724-1726.
30. Simile M, Pascale RM, DeMiglio MR, Nafris A, Daino L, Seddau MA, Muroni MR, Rao KN & Feo F. Inhibition by dehydroepiandrosterone of growth and progression of persistent liver nodules in experimental rat liver carcinogenesis. International Journal of Cancer 1995 62 210-215.
31. Li S, Yan X, Belanger A & Labrie F. Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat. Breast Cancer and Research and Treatment 1994 29 203-217.
32. Schwartz AG, Pashko L & Whitcomb JM. Inhibition of tumor development by dehydroepiandrosterone and related steroids. Toxicologic Pathology 1986 14 357-362.
33. Lucas JA, Ahmed S, Casey ML & MacDonald PC. Prevention of autoantibody formation and prolonged survival in New Zealand Black/New Zealand White F mice fed dehydroepiandrosterone. Journal of Clinical Investigation 1985 75 2091-2093.
34. Leiter EH, Coleman DL & Hummel KP. The influence of genetic background on the expression of mutations at the diabetes locus in mouse. III. Effect of H-2 haplotype and sex. Diabetes 1981 30 1029-1034.
35. Mohan PF & Jacobsen MS. Inhibition of macrophage superoxide generation by dehydroepiandrosterone. American Journal of Medical Sciences 1993 306 10-15.
36. Like AA, Butler L, Williams RM, Appel MC, Weringer EJ & Rossini AA. Spontaneous autoimmune diabetes mellitus in the BB rat. Diabetes 1982 31 7-13.
37. Yale JF & Marliss EB. Altered immunity and diabetes in the BB rat. Clinical and Experimental Immunology 1984 57 1-11.
38. Rossini AA, Mordes JP & Like AA. Immunology of insulin-dependent diabetes mellitus. Annual Review of Immunology 1985 3 291-322.
39. Sternthal E, Like AA, Sarantis K & Braverman LE. Lymphocytic thyroiditis and diabetes in the BB/Wor rat. Diabetes 1981 30 1058-1061.
40. Rajatanavin R, Appel MC, Reinhardt W, Alex S, Yang YM & Braverman LE. Variable prevalence of lymphocytic thyroiditis among diabetes-prone sublines of BB/Wor rats. Endocrinology 1991 128 153-157.
41. Allen EM, Appel MC & Braverman LE. The effect of iodine ingestion on the development of spontaneous lymphocytic thyroiditis in the diabetes prone BB/Wor rat. Endocrinology 1986 118 1977-1981.
42. Bagchi N, Brown TR, Vrdaniria E & Sundick RS. Induction of autoimmune thyroiditis in chickens by dietary iodine. Science 1985 230 325-327.
43. Allen EM & Braverman LE. The effect of iodine on lymphocytic thyroiditis in the thymectomized buffalo rat. Endocrinology 1990 127 1613-1616.
44. Rasooly L, Burek CL & Rose NR. Iodine induced autoimmune thyroiditis in NOD-H-2h4 mice. Clinical Immunology and Immunopathology 1996 81 287-292.
45. Spencer NFL, Poynter ME, Hennebold JD, Mu HH & Daynes RA. Does DHEAS restore immune competence in aged animals through its capacity to function as a natural modulator of peroxisome activities? Annals of the New York Academy of Sciences 1995 774 200-216.
46. Swenson CD, Gottesman RSS, Belsito DV, Samanich KM, Edington J & Thorbecke GJ. Relationship between humoral immunoaugmenting properties of DHEAS and IgD-receptor expression in young and aged mice. Annals of the New York Academy of Sciences 1995 774 249-258.
47. Luster MI, Hayes HT, Korach K, Tucker AN, Dean JH, Greenlee WF & Boorman GA. Estrogen immunosuppression is regulated through estrogenic responses in the thymus. Journal of Immunology 1984 133 110-116.
48. Blauer KL, Poth M, Rogers WM & Bernton EW. Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 1991 129 3174-3179.
49. Paik SG, Michelis MA, Kim YT & Shen S. Induction of insulin-dependent diabetes by streptozotocin: inhibition by estrogen and potentiation by androgens. Diabetes 1982 31 724-729.
50. Bailey CJ & Ahmed-Sorour H. Role of ovarian hormones in the long term control of glucose homeostasis. Effects on insulin secretion. Diabetologia 1982 19 475-481.
51. Toyoda N, Takei S & Formby B. Effect of 5-alpha dihydrotestosterone on T-cell proliferation of the female non-obese diabetic mouse. Proceedings of the Society for Experimental Biology and Medicine 1996 213 287-293.